Deals & Cases

Andean Telecom Partners acquires BTS Towers

Andean Telecom Partners ("ATP"), a leading owner and operator of telecommunications infrastructure in the Andean Region, acquired BTS Towers ("BTS"), a privately owned provider of telecommunications infrastructure, headquartered...

VISCHER advises on MBO of Ulysse Nardin & Girard-Perregaux

On January 24, 2022, Kering entered into an agreement for the sale of its entire stake (100%) in Sowind Group SA, which owns the Swiss watch manufacturers Girard-Perregaux and Ulysse Nardin, to its current management.

VISCHER...

FairCap has acquired NYCO Flexible Packaging GmbH

FairCap, Germany, has acquired NYCO Flexible Packaging GmbH, Switzerland, from Clondalkin Group, a subsidiary of the Dutch investment company Egeria.

Pandemic-related claims in the context of river Rhine cruises fended off

The Covid pandemic was a particularly strong blow to tourism. This also applies to cruises on the river Rhine where, for months, no cruises could be operated and, subsequently, demand was virtually inexistent. VISCHER successfully...

Gilde Buy Out Partners joins forces with Founders and Management of MBK

Funds advised by Gilde Buy Out Partners, a leading European private equity investor, completed the investment in MBK Fincom ("MBK" or the "Company"), alongside the founders and management which are reinvesting in the business....

NEMIS Technologies AG closed a CHF 7.75m Series A Financing Round

NEMIS Technologies AG closed a CHF 7.75m Series A financing round with the participation of both institutional and private investors.

Rigeto Investors acquired Laser Beauté Med SA

A group of investors advised by Rigeto Unternehmerkapital GmbH has acquired 100% of the shares in Laser Beauté Med SA, headquartered in Sion with additional locations in Monthey and Visp.

Successful clawback after hacking attack

VISCHER, along with local counsel, successfully clawed back several million EUR on behalf of a Swiss private bank.

Sale of deepCDR Biologics AG to Alloy Therapeutics Inc.

deepCDR Biologics AG, ein in Basel ansässiges Start-Up, das sich auf die Entdeckung und Entwicklung von Antikörpern spezialisiert hat, wurde von Alloy Therapeutics Inc., ein in Boston ansässiges Biotechnologieunternehmen, übernommen.

Anaveon to raise CHF 110m in oversubscribed Series B financing

Anaveon AG ("Anaveon"), a Swiss clinical-stage immuno-oncology company, has agreed to a CHF 110m Series B financing.